Macau University of Science and Technology, College of Traditional Chinese Medicine, Macau.
The First Clinical Medical College.
Medicine (Baltimore). 2021 Mar 26;100(12):e25038. doi: 10.1097/MD.0000000000025038.
Fire acupuncture is commonly used for the treatment of psoriasis vulgaris, but the efficacy and safety of fire acupuncture for psoriasis vulgaris remain unclear.
This systematic review and meta-analysis will be conducted and reported strictly according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Five databases including China National Knowledge Infrastructure (CNKI), Wanfang, VIP, Chinese biomedical literature, and Pubmed will be retrieved for potentially eligible studies from their inception to Jan. 2021. All randomized clinical trials comparing fire acupuncture versus no fire acupuncture in the treatment of psoriasis vulgaris will be retrieved and assessed for inclusion. RevMan5.3 software provided by Cochrane collaboration will be used for the analysis. Randomized Clinical Trials Data will be extracted by 2 researchers independently, risk of bias of the meta-analysis will be evaluated based on the Cochrane Handbook for Systematic Reviews of Interventions. The primary endpoint is the total effective rate, the secondary outcomes are the Psoriasis Area Severity Index (PASI) score, the recurrence rate and the adverse reactions.
This study will systematically evaluate the efficacy and safety of fire acupuncture for psoriasis vulgaris. The results will be published in a peer-reviewed journal.
This systematic review will evaluate the effects of fire acupuncture in patients with psoriasis vulgaris, thus providing evidence to the clinical application of this therapy.
火针疗法常用于治疗寻常型银屑病,但火针治疗寻常型银屑病的疗效和安全性仍不清楚。
本系统评价和荟萃分析将严格按照系统评价和荟萃分析的首选报告项目(PRISMA)指南进行和报告。从成立到 2021 年 1 月,将从中国知网(CNKI)、万方、VIP、中国生物医学文献和 Pubmed 这 5 个数据库中检索可能符合条件的研究。将检索并评估所有比较火针与非火针治疗寻常型银屑病的随机临床试验。Cochrane 协作提供的 RevMan5.3 软件将用于分析。两名研究人员将独立提取随机临床试验数据,并根据 Cochrane 干预系统评价手册评估荟萃分析的偏倚风险。主要终点是总有效率,次要结局是银屑病面积严重程度指数(PASI)评分、复发率和不良反应。
本研究将系统评价火针治疗寻常型银屑病的疗效和安全性。研究结果将发表在同行评议的期刊上。
本系统评价将评估火针治疗寻常型银屑病患者的疗效,为该疗法的临床应用提供证据。